Lemaitre Vascular (LMAT) Misses Q3 EPS by 2c

Lemaitre Vascular (NASDAQ: LMAT) reported Q3 EPS of $0.30, $0.02 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $38.4 million versus the consensus estimate of $39.05 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c